Evidence map›Paper›PMID 19767429›Full record

ArticleJournal of bacteriology2009

A protein important for antimicrobial peptide resistance, YdeI/OmdA, is in the periplasm and interacts with OmpD/NmpC.

M Carolina Pilonieta, Kimberly D Erickson, Robert K Ernst, Corrella S Detweiler

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Genome sequence of potential psychobioticMicrobiology resource announcements · 2025
    Article
  3. Article
  4. Low Level of Colistin Resistance andAntibiotics (Basel, Switzerland) · 2022
    Article
  5. Colistin Resistance Mechanisms in HumanAntibiotics (Basel, Switzerland) · 2022
    Article
  6. The Rcs System inFrontiers in microbiology · 2021
    Review
  7. Gene Expression Profiling ofFrontiers in microbiology · 2021
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Evolution of Antibiotic Resistance without Antibiotic Exposure.Antimicrobial agents and chemotherapy · 2017
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

M Carolina PilonietaDepartment of Molecular, Cellular, and Developmental Biology, University of Colorado at Boulder, Boulder, CO 80309, USA.
Kimberly D Erickson
Robert K Ernst
Corrella S Detweiler
University of Colorado Boulder · USUniversity of Maryland, Baltimore · US

Funding

Persistent Systemic Infection of Mice by Salmonella EntericaR01AI072492 · NIAID · UNIVERSITY OF COLORADO · PI DETWEILER, CORRELLA S · 2007 to 2011
$1.8M
The Salmonella RcsC Phosphorelay System and VirulenceR56AI063116 · NIAID · UNIVERSITY OF COLORADO AT BOULDER · PI DETWEILER, CORRELLA · 2005 to 2005
$320k
NIAID NIH HHS R01 AI072492NIAID NIH HHS R01-AI072492NIAID NIH HHS R56 AI063116
6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) kill or prevent the growth of microbes. AMPs are made by virtually all single and multicellular organisms and are encountered by bacteria in diverse environments, including within a host. Bacteria use sensor-kinase systems to respond to AMPs or damage caused by AMPs. Salmonella enterica deploys at least three different sensor-kinase systems to modify gene expression in the presence of AMPs: PhoP-PhoQ, PmrA-PmrB, and RcsB-RcsC-RcsD. The ydeI gene is regulated by the RcsB-RcsC-RcsD pathway and encodes a 14-kDa predicted oligosaccharide/oligonucleotide binding-fold (OB-fold) protein important for polymyxin B resistance in broth and also for virulence in mice. We report here that ydeI is additionally regulated by the PhoP-PhoQ and PmrA-PmrB sensor-kinase systems, which confer resistance to cationic AMPs by modifying lipopolysaccharide (LPS). ydeI, however, is not important for known LPS modifications. Two independent biochemical methods found that YdeI copurifies with OmpD/NmpC, a member of the trimeric beta-barrel outer membrane general porin family. Genetic analysis indicates that ompD contributes to polymyxin B resistance, and both ydeI and ompD are important for resistance to cathelicidin antimicrobial peptide, a mouse AMP produced by multiple cell types and expressed in the gut. YdeI localizes to the periplasm, where it could interact with OmpD. A second predicted periplasmic OB-fold protein, YgiW, and OmpF, another general porin, also contribute to polymyxin B resistance. Collectively, the data suggest that periplasmic OB-fold proteins can interact with porins to increase bacterial resistance to AMPs.

Indexed as

AnimalsAntimicrobial Cationic PeptidesBacterial ProteinsCathelicidinsChromatography, AffinityDrug Resistance, Multiple, BacterialGene Expression Regulation, BacterialImmunoblottingImmunoprecipitationMicePeriplasmPolymerase Chain ReactionPolymyxin BPorinsProtein BindingSalmonella entericaAntimicrobial Cationic PeptidesBacterial ProteinsCathelicidinsOmpD protein, Salmonella typhimuriumPolymyxin BPorins

Identifiers

PMID19767429
PMCPMC2786563
OpenAlexW2102842094

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.